Similarly, COX-2 was also highly detected in lobular and ductal in situ carcinoma, being associated with an increased risk for developing subsequent invasive carcinomas [42,43], hence supporting the role of COX-2 in the early carcinogenesis as well. The gene discussed is PTGS2; the disease is ductal breast carcinoma in situ.